Atopic dermatitis, also known as atopic eczema or eczema, is one of the most common chronic inflammatory skin conditions, affecting people of all ages and genders around the world.1,2 It appears as a rash (or skin lesions), causes itching, and may worsen or flare over time.3 More than “just a rash,” atopic dermatitis can be a potentially debilitating condition that disrupts patients’ daily lives and can negatively impact their emotional well-being.4,5 Specifically, atopic dermatitis can lead to disturbed sleep, embarrassment, and difficulty concentrating, among other things.5 Atopic dermatitis can be classified as mild, moderate, or severe depending on several factors, including the extent and severity of disease.2
While there is no cure for atopic dermatitis, there are treatments available.1 Current treatment options aim to provide improvements in rash and symptom burden, including itch relief, the hallmark symptom of the disease.1,6 However, significant unmet needs remain, and the community is in need of new long-term treatment options for this chronic disease that are both safe and effective.7
At Pfizer, patients are at the center of everything we do. Our work aims to enable freedom from the day-to-day suffering of people living with chronic inflammatory diseases like atopic dermatitis. View the resources below to learn more about atopic dermatitis and our efforts to support people living with this condition.